Skip to main content
Caplight Logo









Curix

Curix

Private
EnschedeHealthcare & Life Scienceshttps://curix.life

Last Round

Grant

Feb 10, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Curix is a medical technology company developing a drug delivery platform that uses a microbubble injector system and focused ultrasound to temporarily open the blood-brain barrier for treating neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Clinical Trials, Compliance & Risk, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

patient access servicescontract research organizationCROhub servicesbusiness process outsourcingBPOpharmacovigilance servicesmedical writinglife science outsourcingpatient support programsregulatory supportoffshore outsourcingdata management servicesAI reportingremote proctoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Curix Comparables

Compare Curix with similar companies based on industry and business-model similarity.

Curix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Inizio
73%
Ergomed plc
70%
Cencora
70%

Curix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 10, 2026
Early FundingNov 21, 2023

Curix Investors

Notable investors and investment history

Curix investors
InvestorRounds
Innovative Health InitiativeGrant
Stichting Twinning ParticipatiesEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 10, 2026

    Received funding from the Innovative Health Initiative.

  • Nov 21, 2023

    Led by Stichting Twinning Participaties, an Impact Investor.

Curix Filings

Explore SEC and related filing metadata, where available.

Curix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Curix's valuation, stock price, and market status.

Is Curix a public or private company?

Curix is a private company.

What is the current stock price of Curix?

Curix is a private company with no public stock price. No recent secondary market data is available.

How much is Curix worth (valuation)?

Valuation information for Curix is not publicly available.

Can I buy Curix stock?

Curix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Curix's last funding round?

Funding round information for Curix is not publicly available.

Who are the main investors in Curix?

Investor information for Curix is not publicly disclosed.

Will Curix IPO soon?

No public IPO plans have been announced for Curix.

How can I track Curix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEnschede
Year Founded2021
Last FundingFeb 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?